• Je něco špatně v tomto záznamu ?

LC-MSn and HR-MS characterization of secondary metabolites from Hypericum japonicum Thunb. ex Murray from Nepalese Himalayan region and assessment of cytotoxic effect and inhibition of NF-κB and AP-1 transcription factors in vitro

G. Peron, J. Hošek, S. Rajbhandary, DR. Pant, S. Dall'Acqua,

. 2019 ; 174 (-) : 663-673. [pub] 20190702

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006170

Hypericum japonicum Thunb. ex Murray is traditionally used in Nepal to treat several diseases, among whom inflammation and acute pain. Although several secondary metabolites from the same Hypericum species have been already characterized and considered for their pharmacological use, an exhaustive phytochemical characterization of H. japonicum from Nepal is lacking, as well as the assessment of its potential pharmacological properties. Hence, the aims of this study were the characterization of a methanolic extract of H. japonicum (HJME) collected from the Northern region of Nepal by LC-MSn and UPLC-QTOF. The assessment of in vitro inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and activator protein 1 (AP-1) transcription factors and HJME's cytotoxic effect on human cell lines was performed to evaluate the potential use of this herb as a source of anti-inflammatory and cytotoxic lead compounds. Fifty-seven phytoconstituents were identified, being mainly flavonoids, phloroglucinols, phenolic acids and xanthones. Although compounds characteristic of H. japonicum were detected (quercetin, quercetin-7-O-α-l-rhamnoside, quercitrin and hyperoside), several others are here reported for the first time in this species. The results from bioassays indicated that HJME could significantly reduce the viability of human THP-1 cells (IC50 = 5.4 ± 1.1 μg mL-1), showing the promising potential of HJME as anti-tumor agent. Furthermore, HJME significantly decreased the activation of both NF-κB and AP-1 at the concentration of 2 μg mL-1. Overall, these data suggest that H. japonicum from Nepal could be used as a source of potential natural anti-inflammatory and anti-tumor lead compounds.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006170
003      
CZ-PrNML
005      
20200526152448.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2019.06.042 $2 doi
035    __
$a (PubMed)31288189
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Peron, Gregorio $u Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy. Electronic address: perongregorio@yahoo.it.
245    10
$a LC-MSn and HR-MS characterization of secondary metabolites from Hypericum japonicum Thunb. ex Murray from Nepalese Himalayan region and assessment of cytotoxic effect and inhibition of NF-κB and AP-1 transcription factors in vitro / $c G. Peron, J. Hošek, S. Rajbhandary, DR. Pant, S. Dall'Acqua,
520    9_
$a Hypericum japonicum Thunb. ex Murray is traditionally used in Nepal to treat several diseases, among whom inflammation and acute pain. Although several secondary metabolites from the same Hypericum species have been already characterized and considered for their pharmacological use, an exhaustive phytochemical characterization of H. japonicum from Nepal is lacking, as well as the assessment of its potential pharmacological properties. Hence, the aims of this study were the characterization of a methanolic extract of H. japonicum (HJME) collected from the Northern region of Nepal by LC-MSn and UPLC-QTOF. The assessment of in vitro inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and activator protein 1 (AP-1) transcription factors and HJME's cytotoxic effect on human cell lines was performed to evaluate the potential use of this herb as a source of anti-inflammatory and cytotoxic lead compounds. Fifty-seven phytoconstituents were identified, being mainly flavonoids, phloroglucinols, phenolic acids and xanthones. Although compounds characteristic of H. japonicum were detected (quercetin, quercetin-7-O-α-l-rhamnoside, quercitrin and hyperoside), several others are here reported for the first time in this species. The results from bioassays indicated that HJME could significantly reduce the viability of human THP-1 cells (IC50 = 5.4 ± 1.1 μg mL-1), showing the promising potential of HJME as anti-tumor agent. Furthermore, HJME significantly decreased the activation of both NF-κB and AP-1 at the concentration of 2 μg mL-1. Overall, these data suggest that H. japonicum from Nepal could be used as a source of potential natural anti-inflammatory and anti-tumor lead compounds.
650    _2
$a antiflogistika $x farmakologie $7 D000893
650    _2
$a antitumorózní látky $x farmakologie $7 D000970
650    _2
$a biotest $7 D001681
650    _2
$a buněčné linie $7 D002460
650    _2
$a viabilita buněk $7 D002470
650    _2
$a chromatografie kapalinová $7 D002853
650    _2
$a flavonoidy $x farmakologie $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a hydroxybenzoáty $x farmakologie $7 D062385
650    _2
$a třezalka $x chemie $7 D020902
650    _2
$a zánět $7 D007249
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a NF-kappa B - podjednotka p50 $x antagonisté a inhibitory $7 D052002
650    _2
$a floroglucinol $x farmakologie $7 D010696
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    _2
$a THP-1 buňky $7 D000074084
650    _2
$a transkripční faktor AP-1 $x antagonisté a inhibitory $7 D018808
650    _2
$a xantony $x farmakologie $7 D044004
651    _2
$a Nepál $7 D009390
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hošek, Jan $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic. Electronic address: jan.hosek@upol.cz.
700    1_
$a Rajbhandary, Sangeeta $u Central Department of Botany, Tribhuvan University, 44600 Kirtipur, Kathmandu, Nepal. Electronic address: s.rajbhandary@cdbtu.edu.np.
700    1_
$a Pant, Deepak Raj $u Central Department of Botany, Tribhuvan University, 44600 Kirtipur, Kathmandu, Nepal. Electronic address: drpant_agbot@yahoo.com.
700    1_
$a Dall'Acqua, Stefano $u Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy. Electronic address: stefano.dallacqua@unipd.it.
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 174, č. - (2019), s. 663-673
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31288189 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526152444 $b ABA008
999    __
$a ok $b bmc $g 1525028 $s 1096226
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 174 $c - $d 663-673 $e 20190702 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...